Home/Filings/4/0000899243-22-020385
4//SEC Filing

Iskra Michael S. 4

Accession 0000899243-22-020385

CIK 0001828443other

Filed

May 31, 8:00 PM ET

Accepted

Jun 1, 4:16 PM ET

Size

13.2 KB

Accession

0000899243-22-020385

Insider Transaction Report

Form 4
Period: 2022-05-27
Iskra Michael S.
Executive Vice President
Transactions
  • Disposition to Issuer

    Stock Option

    2022-05-27208,7350 total
    Exercise: $6.28Exp: 2025-12-21Ordinary Shares, $0.00001 par value (208,735 underlying)
  • Disposition to Issuer

    Stock Option

    2022-05-2779,6700 total
    Exercise: $12.56Exp: 2030-07-27Ordinary Shares, $0.00001 par value (79,670 underlying)
  • Disposition to Issuer

    Ordinary Shares, $0.00001 par value

    2022-05-27150,0000 total
  • Disposition to Issuer

    Stock Option

    2022-05-27239,0100 total
    Exercise: $12.56Exp: 2029-12-20Ordinary Shares, $0.00001 par value (239,010 underlying)
Footnotes (3)
  • [F1]Reflects restricted stock units.
  • [F2]Pursuant to the Business Combination Agreement, dated December 22, 2021 (the "BCA"), by and among Coronado Topco, Inc. ("Coronado Topco"), Laguna Merger Sub, Inc., Orca Holdco, Inc., Orca Holdco 2, Inc., Quidel Corporation and the Issuer, the Issuer became a wholly owned subsidiary of Coronado Topco upon consummation of the business combinations (the "Effective Time"). At the Effective Time: (a) each of the Issuer's ordinary shares was automatically converted into the right to receive (i) 0.1055 shares of common stock of Coronado Topco and (ii) $7.14 in cash; and (b) each restricted stock unit, whether vested or unvested, was converted into a Coronado Topco equity right of the same type and on the same terms and conditions as were applicable to the corresponding restricted stock unit immediately prior to the Effective Time, which right shall be settled in cash upon vesting.
  • [F3]At the Effective Time, each stock option, whether vested or unvested, was converted into (a) a Coronado Topco stock option on the same terms and conditions as were applicable to such stock option immediately prior to the Effective Time, except as adjusted by the BCA, (b) with respect to the portion of such stock option that is vested as of the Effective Time, the right to receive payment, in cash, equal to the cash consideration payable in respect of the Issuer's securities subject to the vested portion of such stock option and (c) with respect to the portion of such stock option that is not vested as of the Effective Time, the right to receive payment, in cash, equal to the cash consideration payable in respect of the Issuer's securities subject to the unvested portion of such stock option when it vests in accordance with its terms.

Issuer

Ortho Clinical Diagnostics Holdings plc

CIK 0001828443

Entity typeother

Related Parties

1
  • filerCIK 0001839432

Filing Metadata

Form type
4
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 4:16 PM ET
Size
13.2 KB